Decreased breast cancer rates among women with choriocarcinoma

Deleep K. Gudipudi, Kimberly Hartzfeld, Nadine Montemarano, Giuseppe Del Priore

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: We hypothesized that exposure to high levels of hCG in women diagnosed with choriocarcinoma would decrease future breast cancer risk. Methods: We used the Surveillance, Epidemiology, and End Results (SEER) registry limited-use database (1973-2004) to search for placenta tumors (ICD-10 C58), i.e. choriocarcinoma (CC). Demographics were obtained including patient ID, primary site, year of diagnosis, sex, race, DOB, age group and survival months. Patients with initial choriocarcinoma were searched for subsequent breast cancers. The cohort diagnosis with CC and subsequent breast cancers were compared to general population-based rates of breast cancer. Results: A query for CC yielded 646 women between the ages 15 and 54 years. Of the 646 women, 422 were white, 129 African-American, and 95 "other". Total women-years of observation were 7165.3 with two CC patients developing breast cancer yielding a breast cancer incidence rate of 27.9/100,000 women-years. The incidence rate ratio(IRR) of the CC cohort to the general population was 0.21 (95% CI(0.145-0.327); P <0.01). In women with CC under the age of 35 years the breast cancer rate was 34.1/100,000, IRR 0.27 (95% CI(0.182-0.386); P <0.01). Controlling for race, breast cancer rates in whites were 49.3/100,000 (IRR 0.37, P <0.01); in African-American 1.3/100,000 (IRR 0.01, P <0.001); and 2.6/100,000 (IRR 0.03, P <0.001) in "others" compared to the general population. Conclusion: Women with prior CC had a 79% reduction in breast cancer risk compared to the general population regardless of age and race. Given the high level of hCG and decreased rate of breast cancer among women with CC, the hypothesis that hCG is protective against breast cancer seems plausible.

Original languageEnglish (US)
Pages (from-to)202-205
Number of pages4
JournalGynecologic Oncology
Volume110
Issue number2
DOIs
StatePublished - Aug 2008
Externally publishedYes

Fingerprint

Choriocarcinoma
Breast Neoplasms
Incidence
African Americans
Population
International Classification of Diseases
Placenta
Registries
Epidemiology
Age Groups
Observation
Demography
Databases

Keywords

  • Breast cancer
  • Choriocarcinoma
  • hCG

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Gudipudi, D. K., Hartzfeld, K., Montemarano, N., & Del Priore, G. (2008). Decreased breast cancer rates among women with choriocarcinoma. Gynecologic Oncology, 110(2), 202-205. https://doi.org/10.1016/j.ygyno.2008.04.011

Decreased breast cancer rates among women with choriocarcinoma. / Gudipudi, Deleep K.; Hartzfeld, Kimberly; Montemarano, Nadine; Del Priore, Giuseppe.

In: Gynecologic Oncology, Vol. 110, No. 2, 08.2008, p. 202-205.

Research output: Contribution to journalArticle

Gudipudi, DK, Hartzfeld, K, Montemarano, N & Del Priore, G 2008, 'Decreased breast cancer rates among women with choriocarcinoma', Gynecologic Oncology, vol. 110, no. 2, pp. 202-205. https://doi.org/10.1016/j.ygyno.2008.04.011
Gudipudi DK, Hartzfeld K, Montemarano N, Del Priore G. Decreased breast cancer rates among women with choriocarcinoma. Gynecologic Oncology. 2008 Aug;110(2):202-205. https://doi.org/10.1016/j.ygyno.2008.04.011
Gudipudi, Deleep K. ; Hartzfeld, Kimberly ; Montemarano, Nadine ; Del Priore, Giuseppe. / Decreased breast cancer rates among women with choriocarcinoma. In: Gynecologic Oncology. 2008 ; Vol. 110, No. 2. pp. 202-205.
@article{b39ba1a8f5d540ee8ee6ca73bcc12e59,
title = "Decreased breast cancer rates among women with choriocarcinoma",
abstract = "Objective: We hypothesized that exposure to high levels of hCG in women diagnosed with choriocarcinoma would decrease future breast cancer risk. Methods: We used the Surveillance, Epidemiology, and End Results (SEER) registry limited-use database (1973-2004) to search for placenta tumors (ICD-10 C58), i.e. choriocarcinoma (CC). Demographics were obtained including patient ID, primary site, year of diagnosis, sex, race, DOB, age group and survival months. Patients with initial choriocarcinoma were searched for subsequent breast cancers. The cohort diagnosis with CC and subsequent breast cancers were compared to general population-based rates of breast cancer. Results: A query for CC yielded 646 women between the ages 15 and 54 years. Of the 646 women, 422 were white, 129 African-American, and 95 {"}other{"}. Total women-years of observation were 7165.3 with two CC patients developing breast cancer yielding a breast cancer incidence rate of 27.9/100,000 women-years. The incidence rate ratio(IRR) of the CC cohort to the general population was 0.21 (95{\%} CI(0.145-0.327); P <0.01). In women with CC under the age of 35 years the breast cancer rate was 34.1/100,000, IRR 0.27 (95{\%} CI(0.182-0.386); P <0.01). Controlling for race, breast cancer rates in whites were 49.3/100,000 (IRR 0.37, P <0.01); in African-American 1.3/100,000 (IRR 0.01, P <0.001); and 2.6/100,000 (IRR 0.03, P <0.001) in {"}others{"} compared to the general population. Conclusion: Women with prior CC had a 79{\%} reduction in breast cancer risk compared to the general population regardless of age and race. Given the high level of hCG and decreased rate of breast cancer among women with CC, the hypothesis that hCG is protective against breast cancer seems plausible.",
keywords = "Breast cancer, Choriocarcinoma, hCG",
author = "Gudipudi, {Deleep K.} and Kimberly Hartzfeld and Nadine Montemarano and {Del Priore}, Giuseppe",
year = "2008",
month = "8",
doi = "10.1016/j.ygyno.2008.04.011",
language = "English (US)",
volume = "110",
pages = "202--205",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Decreased breast cancer rates among women with choriocarcinoma

AU - Gudipudi, Deleep K.

AU - Hartzfeld, Kimberly

AU - Montemarano, Nadine

AU - Del Priore, Giuseppe

PY - 2008/8

Y1 - 2008/8

N2 - Objective: We hypothesized that exposure to high levels of hCG in women diagnosed with choriocarcinoma would decrease future breast cancer risk. Methods: We used the Surveillance, Epidemiology, and End Results (SEER) registry limited-use database (1973-2004) to search for placenta tumors (ICD-10 C58), i.e. choriocarcinoma (CC). Demographics were obtained including patient ID, primary site, year of diagnosis, sex, race, DOB, age group and survival months. Patients with initial choriocarcinoma were searched for subsequent breast cancers. The cohort diagnosis with CC and subsequent breast cancers were compared to general population-based rates of breast cancer. Results: A query for CC yielded 646 women between the ages 15 and 54 years. Of the 646 women, 422 were white, 129 African-American, and 95 "other". Total women-years of observation were 7165.3 with two CC patients developing breast cancer yielding a breast cancer incidence rate of 27.9/100,000 women-years. The incidence rate ratio(IRR) of the CC cohort to the general population was 0.21 (95% CI(0.145-0.327); P <0.01). In women with CC under the age of 35 years the breast cancer rate was 34.1/100,000, IRR 0.27 (95% CI(0.182-0.386); P <0.01). Controlling for race, breast cancer rates in whites were 49.3/100,000 (IRR 0.37, P <0.01); in African-American 1.3/100,000 (IRR 0.01, P <0.001); and 2.6/100,000 (IRR 0.03, P <0.001) in "others" compared to the general population. Conclusion: Women with prior CC had a 79% reduction in breast cancer risk compared to the general population regardless of age and race. Given the high level of hCG and decreased rate of breast cancer among women with CC, the hypothesis that hCG is protective against breast cancer seems plausible.

AB - Objective: We hypothesized that exposure to high levels of hCG in women diagnosed with choriocarcinoma would decrease future breast cancer risk. Methods: We used the Surveillance, Epidemiology, and End Results (SEER) registry limited-use database (1973-2004) to search for placenta tumors (ICD-10 C58), i.e. choriocarcinoma (CC). Demographics were obtained including patient ID, primary site, year of diagnosis, sex, race, DOB, age group and survival months. Patients with initial choriocarcinoma were searched for subsequent breast cancers. The cohort diagnosis with CC and subsequent breast cancers were compared to general population-based rates of breast cancer. Results: A query for CC yielded 646 women between the ages 15 and 54 years. Of the 646 women, 422 were white, 129 African-American, and 95 "other". Total women-years of observation were 7165.3 with two CC patients developing breast cancer yielding a breast cancer incidence rate of 27.9/100,000 women-years. The incidence rate ratio(IRR) of the CC cohort to the general population was 0.21 (95% CI(0.145-0.327); P <0.01). In women with CC under the age of 35 years the breast cancer rate was 34.1/100,000, IRR 0.27 (95% CI(0.182-0.386); P <0.01). Controlling for race, breast cancer rates in whites were 49.3/100,000 (IRR 0.37, P <0.01); in African-American 1.3/100,000 (IRR 0.01, P <0.001); and 2.6/100,000 (IRR 0.03, P <0.001) in "others" compared to the general population. Conclusion: Women with prior CC had a 79% reduction in breast cancer risk compared to the general population regardless of age and race. Given the high level of hCG and decreased rate of breast cancer among women with CC, the hypothesis that hCG is protective against breast cancer seems plausible.

KW - Breast cancer

KW - Choriocarcinoma

KW - hCG

UR - http://www.scopus.com/inward/record.url?scp=47249109773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47249109773&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2008.04.011

DO - 10.1016/j.ygyno.2008.04.011

M3 - Article

VL - 110

SP - 202

EP - 205

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -